MJFF, Intel join hands to improve Parkinson’s disease monitoring, treatmentAugust 18, 2014
Karachi: The Michael J Fox Foundation for Parkinson’s Research (MJFF) and Intel Corporation on Tuesday joined hands to improve research and treatment for Parkinson’s disease – a neurodegenerative brain disease second only to Alzheimer’s in worldwide prevalence, through advance technologies.
The collaboration includes a multiphase research study using a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms. This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in drug development.
“Nearly 200 years after Parkinson’s disease was first described by Dr James Parkinson in 1817, we are still subjectively measuring Parkinson’s disease largely the same way doctors did then,” said Todd Sherer, CEO of The Michael J Fox Foundation. “Data science, wearable computing and data from other sources hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.”
“The variability in Parkinson’s symptoms creates unique challenges in monitoring progression of the disease,” said Diane Bryant, senior vice president and general manager of Intel’s Data Centre Group. “Emerging technologies can not only create a new paradigm for measurement of Parkinson’s, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research.”
The post MJFF, Intel join hands to improve Parkinson’s disease monitoring, treatment appeared first on Pakistan Press International.